Detalhe da pesquisa
1.
Nivolumab versus irinotecan as third- or later-line treatment for advanced gastric cancer: a multi-center retrospective study.
Int J Clin Oncol
; 28(6): 756-763, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36943545
2.
Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine derivatives as novel selective Axl inhibitors.
Bioorg Med Chem Lett
; 48: 128247, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34271070
3.
Discovery of a potent and selective Axl inhibitor in preclinical model.
Bioorg Med Chem
; 39: 116137, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33930844
4.
An observational study on nutrition status in gastric cancer patients receiving ramucirumab plus taxane: BALAST study.
Future Oncol
; 17(19): 2431-2438, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33764163
5.
Associations between early tumor shrinkage and depth of response and clinical outcomes in patients treated with 1st-line chemotherapy for advanced gastric cancer.
Gastric Cancer
; 21(2): 267-275, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28584889
6.
A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma.
Int J Clin Oncol
; 23(1): 92-97, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28913565
7.
Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients.
BMC Cancer
; 17(1): 38, 2017 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28068936
8.
Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis.
Int J Clin Oncol
; 22(6): 1060-1068, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28748355
9.
[Chemotherapeutic Strategies for Peritoneal Dissemination of Gastric Cancer].
Gan To Kagaku Ryoho
; 43(13): 2477-2480, 2016 Dec.
Artigo
em Japonês
| MEDLINE | ID: mdl-28028252
10.
Multitargeting strategy using lenvatinib and golvatinib: maximizing anti-angiogenesis activity in a preclinical cancer model.
Cancer Sci
; 106(2): 201-7, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25458359
11.
Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway-induced resistance to vascular endothelial growth factor receptor inhibitor.
Cancer Sci
; 105(6): 723-30, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24689876
12.
[A case of gastric carcinosarcoma treated with surgical resection and irinotecan and mitomycin C combination therapy].
Nihon Shokakibyo Gakkai Zasshi
; 111(1): 105-14, 2014 Jan.
Artigo
em Japonês
| MEDLINE | ID: mdl-24390265
13.
Prognostic Factors in Patients with Advanced HER2-Positive Gastric Cancer Treated with Trastuzumab-Based Chemotherapy: a Cohort Study.
J Gastrointest Cancer
; 54(2): 475-484, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35435573
14.
ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs.
Mol Cancer Ther
; 22(1): 12-24, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36279567
15.
E7386, a Selective Inhibitor of the Interaction between ß-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
Cancer Res
; 81(4): 1052-1062, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33408116
16.
E7050: a dual c-Met and VEGFR-2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models.
Cancer Sci
; 101(1): 210-5, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19832844
17.
Discovery of anti-inflammatory clinical candidate E6201, inspired from resorcylic lactone LL-Z1640-2, III.
Bioorg Med Chem Lett
; 20(10): 3155-7, 2010 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20399648
18.
Discovery of an in vitro and in vivo potent resorcylic lactone analog of LL-Z1640-2 as anti-inflammatory lead, II.
Bioorg Med Chem Lett
; 20(10): 3047-9, 2010 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20427182
19.
Chemoradiotherapy with FOLFOX for esophageal squamous cell cancer with synchronous rectal cancer: Four case reports and a literature review.
Mol Clin Oncol
; 12(1): 23-30, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31814973
20.
Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxel.
Oncotarget
; 9(20): 15219-15227, 2018 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29632638